Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
FP-045 by Foresee Pharmaceuticals for Fanconi Anemia: Likelihood of Approval
FP-045 is under clinical development by Foresee Pharmaceuticals and currently in Phase II for Fanconi Anemia. According to GlobalData, Phase...
FP-045 by Foresee Pharmaceuticals for Pulmonary Arterial Hypertension: Likelihood of Approval
FP-045 is under clinical development by Foresee Pharmaceuticals and currently in Phase I for Pulmonary Arterial Hypertension. According to GlobalData,...
FP-045 by Foresee Pharmaceuticals for Fanconi Anemia: Likelihood of Approval
FP-045 is under clinical development by Foresee Pharmaceuticals and currently in Phase II for Fanconi Anemia. According to GlobalData, Phase...